Showing 8161-8170 of 20420 results for "".
Understanding Endocrine Resistance in HR+/HER2- mBC
https://reachmd.com/programs/cme/Understanding-Endocrine-Resistance-in-HR-HER2-mBC/37323/Join Drs. Jhaveri and Kalinsky and get up to speed on the latest data on PI3K-directed therapies and their role in the treatment paradigm for HR+, HER2- mBC.Targeting Variability: A New Look at Systemic Therapies in Pediatric Severe Atopic Dermatitis
https://reachmd.com/programs/dermconsult/targeting-variability-a-new-look-at-systemic-therapies-in-pediatric-severe-atopic-dermatitis/36439/Real-World Data Highlights Class-Based Differences in Psoriasis Biologic Outcomes
https://reachmd.com/programs/dermconsult/real-world-data-highlights-class-based-differences-in-psoriasis-biologic-outcomes/36369/Exploring the Connection Between E-Cigarette Use and Psoriasis
https://reachmd.com/programs/clinicians-roundtable/exploring-the-connection-between-e-cigarette-use-and-psoriasis/36367/While cigarette smoking is known to be linked to psoriasis, it was unclear whether or not e-cigarette use also carries risk. To address this research gap, a recent study analyzed data from over 28,000 United States adults, and, after adjusting for potential confounding variables, found that there isExploring Timing in MS Therapy: Real-World Outcomes of Fumarates
https://reachmd.com/programs/neurofrontiers/exploring-timing-in-ms-therapy-real-world-outcomes-of-fumarates/32805/Defining the Standard of Care and Optimal Sequencing in BRAF-Mutant mCRC: Second Line and Beyond
https://reachmd.com/programs/cme/DefiningtheStandardofCareandOptimalSequencinginBRAFMutantmCRcSecondLineandBeyond/32944/Explore expert recommendations for optimizing clinical outcomes with targeted treatment combinations in BRAF-mutant mCRC.Navigating the New Breastfeeding Recommendations for HIV Patients
https://reachmd.com/programs/clinicians-roundtable/navigating-the-new-breastfeeding-recommendations-for-hiv-patients/16178/What are the new recommendations for patients with HIV who’d like to breastfeed? Find out with this recap of a session featured at ANAC.Diving into the Efficacy & Tolerability of mBC Treatment
https://reachmd.com/programs/project-oncology/diving-into-the-efficacy-tolerability-of-mbc-treatment/15818/An oral chemotherapy drug is preferred by physicians and patients for mBC patients. However, the current approved dosing has cumulative toxicity.Addressing Treatment Challenges in Hepatitis C
https://reachmd.com/programs/gi-insights/addressing-treatment-challenges-in-hepatitis-c/14241/What do clinicians need to know to enhance their understanding when it comes to treating patients with hepatitis C? Tune in.Clinical dilemmas in heart failure: Weighing the balance of RAASi and hyperkalaemia
https://reachmd.com/programs/video-library/clinical-dilemmas-in-heart-failure-weighing-the-balance-of-raasi-and-hyperkalaemia/14739/This discussion is part of a series titled "Clinical dilemmas in heart failure: Weighing the balance of RAASi and hyperkalaemia".